Wellington Management Group LLP Has $372.21 Million Stock Holdings in Encompass Health Co. (NYSE:EHC)

Wellington Management Group LLP lowered its holdings in Encompass Health Co. (NYSE:EHC - Free Report) by 22.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4,030,442 shares of the company's stock after selling 1,189,732 shares during the quarter. Wellington Management Group LLP owned about 4.00% of Encompass Health worth $372,211,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in EHC. BNP Paribas Financial Markets increased its position in Encompass Health by 38.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 38,397 shares of the company's stock valued at $3,711,000 after acquiring an additional 10,591 shares in the last quarter. Townsquare Capital LLC acquired a new stake in shares of Encompass Health in the third quarter valued at approximately $405,000. Point72 Asia Singapore Pte. Ltd. raised its position in Encompass Health by 62.0% in the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 1,095 shares of the company's stock worth $106,000 after purchasing an additional 419 shares during the last quarter. Benjamin Edwards Inc. lifted its holdings in Encompass Health by 37.2% during the 3rd quarter. Benjamin Edwards Inc. now owns 6,298 shares of the company's stock worth $609,000 after buying an additional 1,707 shares in the last quarter. Finally, Cinctive Capital Management LP boosted its position in Encompass Health by 33.5% in the 3rd quarter. Cinctive Capital Management LP now owns 38,381 shares of the company's stock valued at $3,709,000 after buying an additional 9,626 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Insider Buying and Selling

In related news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the transaction, the chief accounting officer now owns 69,164 shares in the company, valued at approximately $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 2.10% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research firms have issued reports on EHC. StockNews.com downgraded shares of Encompass Health from a "buy" rating to a "hold" rating in a research report on Thursday. Barclays lifted their target price on shares of Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a report on Friday, February 7th. KeyCorp increased their price target on Encompass Health from $117.00 to $120.00 and gave the company an "overweight" rating in a research note on Monday, February 10th. William Blair restated an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. Finally, Royal Bank of Canada restated an "outperform" rating and set a $110.00 price objective on shares of Encompass Health in a report on Tuesday, February 11th. One investment analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Buy" and an average target price of $107.67.

Encompass Health Stock Down 3.7 %

NYSE EHC traded down $3.73 during trading on Friday, hitting $98.14. The stock had a trading volume of 1,218,251 shares, compared to its average volume of 646,649. The company has a market capitalization of $9.88 billion, a PE ratio of 22.00, a P/E/G ratio of 2.31 and a beta of 0.87. Encompass Health Co. has a 12 month low of $78.53 and a 12 month high of $104.55. The company's 50-day moving average price is $99.25 and its two-hundred day moving average price is $97.75. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. As a group, sell-side analysts forecast that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 0.69%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health's dividend payout ratio (DPR) is 15.25%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.